RegeneSlim
Published April 12, 2017 · Recall initiated: March 9, 2017
Summary
FDA records food Class II recall F-1819-2017, published April 12, 2017 and initiated March 9, 2017. Recalling firm: VivaCeuticals, Inc. dba Regeneca Worldwide; Status: Terminated; Reported quantity: 4000 units; Lot: Lot AAMXG. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The firm is recalling all herbal and dietary supplements because they were not manufactured in compliance with the current Good Manufacturing Practice regulations for Dietary Supplements.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- VivaCeuticals, Inc. dba Regeneca Worldwide
- Distributor
- US
- Lot
- Lot AAMXG
- Risk classification
- Class II
- Area (FDA)
- food
- Country
- United States
Related recalls
- FDARegeneBlendApril 12, 2017
- FDARegeneArouseApril 12, 2017
- FDARegeneBlastApril 12, 2017
- FDARegeneFitApril 12, 2017
- FDAQuinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09April 12, 2017
- FDARIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's LaboratoriesApril 12, 2017
Questions about this recall
Was RegeneSlim recalled?
Yes. FDA published recall F-1819-2017 on April 12, 2017. Reported hazard: The firm is recalling all herbal and dietary supplements because they were not manufactured in compliance with the current Good Manufacturing Practice regulations for Dietary Supplements.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release